Cannabis advocates in Oklahoma have filed ballot initiatives for 2022 to legalize adult-use cannabis and replace the current medical cannabis oversight agency, the Tulsa World reports.
INVESTOR PROFILE | Ionic Brands
Company:
Ionic Brands
Symbol:
CSE: IONC
Country:
United States
Sector:
Legal Recreational Marijuana
Industry:
Concentrates and Vapes
Established:
2015
Website:
Company:
Ionic Brands
Symbol:
CSE: IONC
Country:
United States
Sector:
Legal Recreational Marijuana
Industry:
Concentrates and Vapes
Established:
2015
Website:
52-Week
Range N/A
Range N/A
Current
Outstanding 108,436,715
Outstanding 108,436,715
Warrants
Options
Fully Diluted
Market Cap.
14,639,000
14,639,000
IONIC BRANDS (CSE: IONC) has a premium portfolio of cannabis concentrate consumer brands. Ionic Brands is one of the top selling concentrate company in Washington State.
Company Brief
Ionic Brands (CSE: IONC) is creating a multi-state, consumer focused, premium cannabis porfolio consisting of iconic national brands.
They have:
- Stylish products
- World Class Management Team
- A proven and repeatable strategy for success
Highlights
Experienced and proven luxury cannabis concentrates brand
One of the tops selling vape brands in WA State with a loyal customer base
Largest standalone oil manufacturer in the state of WA
Consistent sales growth over 3 years with a verified marketing blueprint
Offers investors exposure to a premium luxury cannabis brand
Demonstrated to have a winning formula to become the top vape company in WA
Massive growth opportunity available with expansion into OR, NV and CA
In The News
Ionic Is Changing the Face of Cannabis and Creating a Social Revolution
It’s all in the URL: Ionic.social. “We believe our products are best when enjoyed in a social setting,” said co-founder Christian Struzan.
READ MORE
Marijuana Vaping Is The Most Explosive Growth Play In Marijuana Today
“Nobody smokes marijuana anymore, they vape it.” - New York Times That's not quite true. But it will be soon.
READ MORE
How To Invest In Marijuana Vaping
The marijuana vaporization products (or just "vape") market is set to explode in 2019.
READ MORE
Related Articles
GOP Pennsylvania Lawmaker Files Psilocybin Research Bill For Veterans And First Responders
A coalition of Pennsylvania lawmakers introduced a bill this week that’s meant to promote research into the therapeutic potential of psilocybin mushrooms for mental health conditions such as post-traumatic stress disorder —the latest example of how the psychedelics reform movement is gaining momentum.
Congressman Says He’ll Bring The Psychedelics Reform Movement To Capitol Hill ‘This Year’
A congressman said on Wednesday that he intends to help bring the psychedelics reform movement to Capitol Hill “this year.”
Novamind Launches New Psychedelic Palliative Care Program
Novamind is expanding its mental health care to include the treatment of patients with palliative needs, via its new Murray, Utah treatment clinic.
The Ketamine Renaissance
Psychedelic drugs like psilocybin, LSD and MDMA have amazing medicinal and commercial potential. So does ketamine, but ketamine is already legal.
PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment of Parkinson’s Disease
PharmaTher initiates a Phase 2a clinical trial for a ketamine-based therapy for Parkinson's Disease, expected to commence in October 2021.